{"nct_id":"NCT03932318","title":"Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients","status":"WITHDRAWN","status_verified_date":"2023-07","start_date":"2023-03","start_date_type":"ESTIMATED","primary_completion_date":"2023-12","primary_completion_date_type":"ESTIMATED","completion_date":"2024-09","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["ATNM"]}